Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 30, 2024 | Option Exercise | $0.73 | 2,019 | 1,476 | 193,065 | Jul 02, 2024, 06:12 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 20, 2024 | Buy | $0.74 | 20,508 | 15,254 | 186,132 | Jun 21, 2024, 05:16 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 18, 2024 | Buy | $0.86 | 12,000 | 10,320 | 165,624 | Jun 21, 2024, 05:16 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 13, 2024 | Buy | $0.91 | 12,000 | 10,920 | 129,624 | Jun 17, 2024, 06:08 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 14, 2024 | Buy | $0.93 | 12,000 | 11,176 | 141,624 | Jun 17, 2024, 06:08 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 17, 2024 | Buy | $0.90 | 12,000 | 10,799 | 153,624 | Jun 17, 2024, 06:08 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 03, 2024 | Buy | $0.76 | 12,000 | 9,120 | 105,624 | Jun 05, 2024, 06:12 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 04, 2024 | Buy | $0.78 | 12,000 | 9,360 | 117,624 | Jun 05, 2024, 06:12 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | May 29, 2024 | Buy | $0.64 | 12,000 | 7,643 | 69,624 | May 31, 2024, 04:56 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | May 30, 2024 | Buy | $0.64 | 12,000 | 7,676 | 81,624 | May 31, 2024, 04:56 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | May 31, 2024 | Buy | $0.64 | 12,000 | 7,732 | 93,624 | May 31, 2024, 04:56 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Mar 31, 2024 | Option Exercise | $0.68 | 3,098 | 2,110 | 57,624 | Apr 02, 2024, 08:35 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Dec 31, 2023 | Option Exercise | $0.34 | 3,098 | 1,054 | 51,770 | Jan 03, 2024, 07:39 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Sep 30, 2023 | Option Exercise | $0.62 | 2,624 | 1,627 | 45,916 | Oct 03, 2023, 07:30 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 30, 2023 | Option Exercise | $0.86 | 4,057 | 3,469 | 39,587 | Jul 03, 2023, 06:51 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Dec 31, 2022 | Option Exercise | $2.37 | 1,406 | 3,332 | 26,894 | Jan 03, 2023, 04:07 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Nov 14, 2022 | Buy | $3.00 | 6,053 | 18,159 | 14,238 | Nov 16, 2022, 04:58 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Nov 15, 2022 | Buy | $3.15 | 10,000 | 31,500 | 24,238 | Nov 16, 2022, 04:58 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Sep 30, 2022 | Option Exercise | $1.52 | 1,191 | 1,810 | 8,185 | Oct 03, 2022, 07:42 PM | |
MNPR | Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Jun 30, 2022 | Option Exercise | $2.30 | 2,812 | 6,465 | 5,313 | Jul 01, 2022, 04:17 PM |